Global Omega 3 Market (2021 to 2028) - Size, Share & Trends Analysis Report - ResearchAndMarkets.com
Global Omega 3 Market (2021 to 2028) - Size, Share & Trends Analysis Report - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Omega 3 Market Size, Share & Trends Analysis Report by Type (EPA, DHA), by Source (Marine, Plant), by Application (Supplements & Functional Foods, Infant Formula), by Region (APAC, CSA), and Segment Forecasts, 2020 - 2028" report has been added to ResearchAndMarkets.com's offering.
都柏林--(美国商业新闻网)--《2020-2028年欧米茄3市场规模、份额和趋势分析报告》增加了按类型(EPA、DHA)、来源(海洋、植物)、应用(补充剂和功能食品、婴儿配方奶粉)、地区(APAC、CSA)和细分市场预测的报告Research andMarkets.com的献祭。
The global omega 3 market size is expected to reach USD 3.82 billion by 2028, registering a CAGR of 7.8% over the forecast period. DHA and EPA can help improve brain health in children and heart health in adults, which is likely to boost the market growth. The rising scope of applications of omega 3 in pharmaceuticals is also supporting product consumption. Players are focusing on offering high-quality pharma-grade omega 3. For instance, FMC Corp.'s Epax brand offers concentrated marine omega-3 fatty acids sourced from sustainable and traceable raw materials and caters to the requirements of high-quality pharmaceutical ingredients.
预计到2028年，全球欧米茄3市场规模将达到38.2亿美元，在预测期内实现7.8%的复合年增长率。DHA和EPA可以帮助改善儿童的大脑健康和成年人的心脏健康，这可能会推动市场增长。Omega 3在制药领域的应用范围不断扩大，也在支持产品消费。玩家正专注于提供高质量的药用级omega 3。例如，FMC Corp.的Epax品牌提供浓缩的海洋omega-3脂肪酸，这些脂肪酸来自可持续和可追溯的原材料，并迎合了高质量药物成分的要求。
The global market is characterized by the presence of prominent players, such as BASF SE, Koninklijke DSM N.V., Lonza, and Croda International Plc, which is expected to increase the competition. Players are focusing on catering to specific client requirements to widen the customer base.
全球市场的特点是出现了著名的参与者，如巴斯夫SE、Koninklijke DSM N.V.、Lonza和Croda International Plc，预计这将加剧竞争。玩家正专注于迎合特定的客户需求，以扩大客户基础。
For instance, Crius Life Sciences have the formulation capacity of producing EPA/DHA with concentration level according to the client needs, such functionality offers a higher degree of freedom. Companies are utilizing krill oil as an alternative source to fish oil due to rising levels of contamination in fish oil. For instance, in November 2019, Aker BioMarine and Acasti Pharma signed a krill oil supply agreement to develop an innovative hypertriglyceridemia drug, using krill oil as its core ingredient.
例如，Crius生命科学具有根据客户需求生产浓度水平的EPA/DHA的配方能力，这种功能提供了更高的自由度。由于鱼油的污染水平不断上升，公司正在利用磷虾油作为鱼油的替代来源。例如，2019年11月，Aker BioMarine和Acasti Pharma签署了一项磷虾油供应协议，以开发一种使用磷虾油作为核心成分的创新高甘油三酯血症药物。
Companies Mentioned
提到的公司
- Aker Biomarine Antarctic As
- Basf Se
- Bioprocess Algae, Llc
- Croda International Plc
- Epax
- Gc Reiber Oils
- Koninklijke Dsm N.V.
- Lonza
- Omega Protein Corporation.
- Orkla Health (Axellus)
- Aker Biomarine南极AS
- 巴斯夫Se
- 生物处理藻类有限责任公司
- 克罗达国际公司
- Epax
- GC雷伯油
- Koninklijke DSM N.V.
- 龙沙
- 欧米茄蛋白质公司。
- Orkla Health(Axellus)
Omega 3 Market Report Highlights
欧米茄3市场报告要点
- Eicosapentaenoic Acid (EPA) held a revenue share of 25.3% in 2020 and is expected to grow rapidly over the forecast period owing to the rising demand from the pharmaceutical industry
- For instance, BASF SE offers Maxomega EPA 97 EE eicosapentaenoic acid ethyl ester that can be used in Japanese "Epadel", and American "Vascepa" drugs for its benefits in cardiovascular health
- Manufacturers focus more on new product development to strengthen their market presence. For instance, in November 2019, BASF launched Hepacor, which contains highly concentrated purified EPA and DHA, for the dietary management of Non-Alcoholic Fatty Liver Disease (NAFLD)
- The marine source segment is expected to register the fastest CAGR of 8.1% over the forecast period owing to the rising production of omega 3 from non-fish-based marine sources, such as krill and algal oils
- Algal oil is gaining popularity among vegan consumers as it does not contain traces of fish oil or fishy odor
- Companies are exploring alternative sources to marine species owing to the rising adoption of plant-based products globally
- For instance, in August 2019, Cargill received approval for producing omega 3 sourced from canola, which can be widely used in the aquaculture feed industry
- The infant formula segment is expected to grow at the fastest CAGR over the forecast period owing to the rising awareness about infant nutrition
- Growing consumption of breast milk substitutes, which closely resemble the functionality and composition of breast milk, is also anticipated to drive the infant formula segment
- 二十碳五烯酸(EPA)在2020年的收入份额为25.3%，由于制药行业的需求上升，预计在预测期内将快速增长
- 例如，巴斯夫SE提供Maxomega EPA 97EE二十碳五烯酸乙酯，可以用于日本的Epadel，以及美国的Vascepa药物，因为它对心血管健康有好处
- 制造商更注重新产品的开发，以加强他们的市场占有率。例如，2019年11月，巴斯夫推出了Hephacor，它含有高度浓缩的精制EPA和DHA，用于非酒精性脂肪性肝病(NAFLD)的饮食管理
- 由于磷虾和藻油等非鱼类来源的omega 3产量增加，预计海洋来源部分在预测期内将录得8.1%的最快复合年增长率。
- 海藻油在素食消费者中越来越受欢迎，因为它不含微量鱼油或鱼腥味
- 由于全球越来越多地采用植物性产品，公司正在探索海洋物种的替代来源
- 例如，2019年8月，嘉吉获得批准，可以生产从油菜籽中提取的omega 3，可广泛用于水产养殖饲料行业
- 由于人们对婴儿营养的认识不断提高，预计婴儿配方奶粉市场在预测期内将以最快的复合年增长率增长。
- 与母乳的功能和组成非常相似的母乳替代品的消费不断增长，预计也将推动婴儿配方奶粉细分市场
Key Topics Covered:
涵盖的主要主题：
Chapter 1. Methodology and Scope
第一章方法和范围
Chapter 2. Executive Summary
第2章.执行摘要
Chapter 3. Omega 3 Market: Variables, Trends & Scope
第三章欧米茄3市场：变量、趋势和范围
3.1. Market Lineage Outlook
3.1.市场谱系展望
3.2. Penetration & Growth Prospect Mapping
3.2.渗透率与增长前景图
3.3. Value Chain Analysis
3.3.价值链分析
3.4. Omega-3 Analysis
3.4.Omega-3分析
3.4.1. New Products
3.4.1。新产品
3.5. Technology Overview
3.5.技术概述
3.5.1. Technology Trends
3.5.1。技术趋势
3.5.1.1. Omega-3
3.5.1.1。欧米茄-3
3.5.1.2. Krill Oil
3.5.1.2。磷虾油
3.5.1.2.1. Multi Stage Oil Extraction
3.5.1.2.1。多级采油
3.6. Regulatory Framework
3.6.监管框架
3.6.1. Product Classification Codes
3.6.1.产品分类编码
3.6.2. Standards Andcompliances
3.6.2.标准和合规性
3.6.3. Safety
3.6.3。安全问题
3.7. Market Dynamics
3.7.市场动态
3.7.1. Market Driver Analysis
3.7.1。市场驱动因素分析
3.7.1.1. Rising Penetration of Omega 3 in Active Pharmaceutical Ingredient Market
3.7.1.1。欧米茄3在活性药物成分市场的渗透率上升
3.7.1.2. Growing Demand for Dietary Supplements
3.7.1.2。对膳食补充剂日益增长的需求
3.7.2. Market Restraint Analysis
3.7.2。市场约束分析
3.7.2.1. Declining Growth Rate of Fish Production
3.7.2.1。水产品产量增速下降
3.7.3. Industry Challenges
3.7.3。行业挑战
3.7.3.1. Restricted Supply of Alternative Sources
3.7.3.1。替代来源的有限供应
3.8. Business Environmental Analysis
3.8.营商环境分析
3.9. Market Entry Strategies
3.9.市场进入策略
Chapter 4. Omega 3 Market: Type Estimates & Trend Analysis
第四章欧米茄3市场：类型估计和趋势分析
Chapter 5. Omega 3 Market: Source Estimates & Trend Analysis
第5章欧米茄3市场：来源估计和趋势分析
Chapter 6. Omega 3 Market: Application Estimates & Trend Analysis
第6章欧米茄3市场：应用评估和趋势分析
Chapter 7. Carrageenan Market: Regional Estimates & Trend Analysis
第7章卡拉胶市场：区域估计和趋势分析
Chapter 8. Competitive Landscape
第八章.竞争格局
Chapter 9. Company Profiles
第9章.公司概况
For more information about this report visit
有关本报告的更多信息，请访问
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
ResearchAndMarkets.com
高级新闻经理劳拉·伍德
邮箱：Press@researchandMarkets.com
东部夏令时办公时间请拨打1-917-300-0470
美国/加拿大免费电话：1-800-526-8630
对于格林尼治标准时间办公时间，请致电+353-1-416-8900
译文内容由第三方软件翻译。